Fig 5 -

Fig 5 -

<p>Funnel plots of survival (A), EFSR (B), pathological responses (C), and safety summary (D).</p>

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Hai Huang (140371) (author)
مؤلفون آخرون: Lianyun Li (3435095) (author), Ling Tong (632992) (author), Houfu Luo (19727416) (author), Huijing Luo (19727419) (author), Qimin Zhang (17692601) (author)
منشور في: 2024
الموضوعات:
Biochemistry
Medicine
Cell Biology
Pharmacology
Biotechnology
Developmental Biology
Cancer
treatment discontinuations due
shown promising results
6 &# 8211
12 &# 8211
major pathological response
significantly improve survival
prolonged survival times
ppi group experienced
5 aes must
rr ]: 5
77 ]), event
xlink "> pd
hr ]: 0
xlink ">
5 aes
pathological responses
serious aes
free survival
substantial evidence
still lacking
seen across
scale studies
risk ratio
resectable nsclc
resectable non
rcts ),
r0 resections
primary endpoint
ppi cohort
perioperative setting
perioperative pd
nsclc ).
l1 inhibitors
increased incidence
hazard ratio
analysis based
analysis aims
adverse events
adjuvant therapies
82 ]).
57 ]),
48 months
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة

مواد مشابهة